The disruption of MDM2-VEGF mRNA binding by gossypol results in decreased MDM2 and VEGF protein expression, which can contribute to both cancer cells death and anti-angiogenesis in breast cancer [78].Fig. 7 illustrates the anti-angiogenic mechanism of gossypol in cancer cells (Fig. 7). This evidence concerns the gene MDM2 and breast carcinoma.